NVS NOVELSTAR PHARMACEUTICALS INC.
Live / Allowed — Published for opposition (as of 21 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 15 Aug 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97549234
- Mark type
- Design + words
- Filed
- 15 Aug 2022
- Published for opposition
- 21 Jul 2026
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations for use in treatment of human diseases and disorders, namely, skin disorders, eye disorders, cardiovascular diseases, diseases of the digestive systems, diseases of the blood system, neurological diseases, musculoskeletal diseases, infectious diseases, urological diseases, immunological diseases, allergies, wounds, hypertension, cancer, pain, diabetes
Owner
- Novelstar Pharmaceuticals Inc., Cranbury, NJ, US
- Novelstar Pharmaceuticals Inc., Cranbury, NJ, US
Prosecution history
- 08 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 21 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jul 2026 — PUBLISHED FOR OPPOSITION
- 15 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Jun 2026 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 10 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Apr 2025 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 05 Nov 2024 — ASSIGNED TO EXAMINER
- 04 Nov 2024 — ASSIGNED TO EXAMINER
- 04 Nov 2024 — ASSIGNED TO EXAMINER
- 25 Jul 2024 — CASE RETURNED TO EXAMINATION
- 25 Jul 2024 — NOTICE OF ALLOWANCE CANCELLED
- 16 Jul 2024 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 16 Jul 2024 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED